to treat conditions such as heartburn. It belongs to a class of drugs known as proton pump inhibitors (PPIs), which also include lansoprazole, pantoprazole, and esomeprazole. These medications reduce stomach acid production, but long-term use has been associated with serious risks to brain health. Epidemiological studies show a link between PPIs and an increased risk of dementia and memory loss.
In a study of 6,000 participants, 10% of those taking omeprazole for 3 years experienced memory loss. Another study found that 33% of patients taking the drug for more
